--------- June 24 - 07 ---------

 

+++ PharmCast.com's Executive MBA Program Highlight+++

The University of Colorado Executive MBA Program in Health Administration offers an option in Pharmaceutical Management that provides pharmaceutical industry professionals with a Master of Business Administration degree with an emphasis in health administration and pharmaceutical management in 25 months.  Professionals in the pharmaceutical industry are being faced with management issues that are complex and involve other key players in the health care industry.  Students will learn about global issues in a classroom environment that includes a wide variety of healthcare professionals.

http://www.pharmcast.com/BuyersGuide/UColorado/UColoradoMBAInfo.htm


 

+++ PharmCast.com's Conference Highlight +++
 

1.  Cleanroom Microbiology for the Non-Microbiologist, July 16-17, 2007, Costa Mesa, CA.  Organized by The Center for Professional Innovation & Education.

http://www.cfpie.com/showitem.aspx?productid=016&source=pharmcast
 

2.  Web Seminar: Incorporating Audit into Operational Framework, June 26. 2007.  Speaker: Bernice Russell-Bond, President, BRUSSELL Consulting, Inc.  Organized by BenAstrum, Inc.

http://benastrum.com/10.html
 

3.  Ion Channel Targets, September 10-11, 2007, Boston, MA.  Organized by Select Biosciences Ltd.

http://www.selectbiosciences.com/conferences/ICT2007/
 

4.  2nd Annual Generic Licensing, September 12-13, 2007, Budapest, Hungary.  Organized by Jacob Fleming Conferences.

http://www.jacobfleming.com/buxus/generate_page.php?page_id=578
 

5.  The 6th Successful Investigator Initiated Trial Programs, September 13-14, 2007, San Francisco, CA.  Organized by ExL Pharma.

http://www.exlpharma.com/eventDetail.php?id=78
 

6.  Discovery-2-Diagnotics, September 17-19, 2007, Philadelphia, PA. Sponsored by IBC Life Sciences.

http://www.discovery2diagnostics.com
 

5.  PharmaForce 2007: The Premier North American Pharmaceutical Sales Force Effectiveness Conference, September 17-19, 2007, Philadelphia, PA.  Organized by Worldwide Business Research.

http://www.wbresearch.com/pharmaforceusa/index.asp?cm_mmc=Affiliate-_-Listing-_-11869.001-_-PharmCast
 

+++ PharmCast.com's Last Week Pharmaceutical Patents +++
 

http://www.pharmcast.com/PatentToSubWeb/Yr2007/June2007/Home060507OG.htm


1.  Peptide inhibitors of HIV entry

2.  Hepatitis C virus non-structural NS3/4A fusion gene

3.  Material for controlling diversion of medications

4.  Equine Fc epsilon receptor alpha protein

5.  Targeted chromosomal genomic alterations with modified single stranded oligonucleotides

6.  Directly compressible tricalcium phosphate

7.  Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders

8.  Protein C or activated protein C-like molecules

9.  Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same

10.  Preparation for the prevention and/or treatment of vascular disorders

11.  Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate

12.  Identification and mapping of single nucleotide polymorphisms in the human genome

13.  Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof

14.  Self-emulsifying drug delivery system

15.  Human antibodies that bind human 17-A1/EpCAM tumor antigen

16.  Signal for packaging of influenza virus vectors

17.  Methods of inhibiting transmission of a costimulatory signal of lymphocytes

18.  Seamless filled capsules

19.  Nucleic acid vaccines for prevention of flavivirus infection

20.  Method of removing endotoxin from vaccines

+++ PharmCast.com's Last Week Federal Register +++
 

http://www.pharmcast.com/FederalRegistrar/FRHome.htm
 

June 22, 2007

1.  Presidential Document: Executive Order 13435--Expanding Approved Stem Cell Lines in Ethically Responsible Ways

2.  Notice: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Special Protocol Assessment

June 21, 2007

1.  Notice: International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); Revised Draft Guidance for Industry on Pharmacovigilance of Veterinary Medicinal Products: Controlled List of Terms (VICH GL30); Request for Comments; Availability

2.  Notice: Draft Guidance for Industry on Use of the Computer Crossmatch; Availability

3.  Notice: Guidance for Industry: Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs; Availability

June 20, 2007

1.  Notice: Prospective Grant of Exclusive License: Anti-Mesothelin Antibodies Useful for Immunological Assays

2.  Notice (A): Government-Owned Inventions; Availability for Licensing

3.  Notice (B): Government-Owned Inventions; Availability for Licensing

4.  Notice (C): Government-Owned Inventions; Availability for Licensing

5.  Notice (D): Government-Owned Inventions; Availability for Licensing

6.  Notice (E): Government-Owned Inventions; Availability for Licensing

June 19, 2007

1.  Notice: Guidance for Industry and Food and Drug Administration Staff; Pharmacogenetic Tests and Genetic Tests for Heritable Markers; Availability

2.  Final Rule: Human Cells, Tissues, and Cellular and Tissue-Based Products; Donor Screening and Testing, and Related Labeling

June 18, 2007

1.  Notice: Anthrax Vaccines--Bridging Correlates of Protection in Animals to Immunogenicity in Humans; Public Workshop

2.  Notice: Licensure of Apheresis Blood Products; Public Workshop

+++ PharmCast.com's Last Week Recent FDA Links +++

 http://www.pharmcast.com/FDALinks/FDALinksLatest.htm
 

June 22, 2007

1.  FDA News: FDA approves Lyrica (pregabalin), the first drug to treat fibromyalgia, a disorder characterized by pain, fatigue and sleep problems. (6/22/2007)

2.  Office of Nonprescription Drugs: Chronological List of All NDAC Meetings (1992 to Present) (6/22/2007)

June 20, 2007

1.  Guidance for Industry: Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs (Posted 6/20/2007)

2.  Draft Guidance for Industry: “Computer Crossmatch” (Electronic Based Testing for the Compatibility between the Donor’s Cell Type and the Recipient’s Serum or Plasma Type) (Posted 6/20/2007)

June 19, 2007

1.  FEDERAL REGISTER Human Cells, Tissues, and Cellular and Tissue-Based Products; Donor Screening and Testing, and Related Labeling; Final Rule (Posted: 6/19/2007, Publish Date: 6/19/2007)

June 18, 2007

1.  On June 15, FDA approved Letairis (ambrisentan) for the treatment of pulmonary arterial hypertension. FDA News (6/18/2007)

+++ PharmCast.com's Recent FDA Warning Letters +++

http://www.pharmcast.com/WarningLetters/LatestWL.htm
 

1.  Allergan, Inc. (ACULAR LS® (ketorolac tromethamine ophthalmic solution) 0.4%)

_____________________________________________________________

PharmCast Dot Com, the Official www.PharmCast.com's Newsletter.

Copyright GF Communications
To ***, please go to:

http://www.pharmcast.com/Newsletter/***nl.htm

patents * jobs * Federal Register * news * stocks * FDA Links * Buyer's Guide